Quick Answer
CANNAPHARMARX, INC. reported Gross Profit of -$2.08 million for the year ending 2025.
- CANNAPHARMARX, INC. showed an increase of +29.0% in Gross Profit from 2024 to 2025.
- This data is from CANNAPHARMARX, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $0.00 | Q2 2023: $0.00 | Q3 2023: $0.00 | Q1 2024: -$437.4 thousand | Q2 2024: -$171.4 thousand | Q3 2024: -$356.2 thousand | Q1 2025: -$502.6 thousand | Q2 2025: -$621.2 thousand | Q3 2025: -$440.0 thousand.
- Historical annual values: Fiscal year 2025: -$2.08 million | Fiscal year 2024: -$2.93 million | Fiscal year 2023: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: